Trials / Completed
CompletedNCT06610032
The Effect of Mesotherapy and Intra-articular Steroid Injection in Shoulder Pain
The Comparison o the Efficacy of Mesotherapy and Intra-articular Steroid Injection in Patients With Chronic Shoulder Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Haydarpasa Numune Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients with chronic shoulder pain will be divided randomly into mesotherapy and intra-articular steroid injection groups. Pain severity, range of motion and functional impairment will evaluated before treatment, 30 minutes and 4 weeks after the injections.
Detailed description
The study will include 84 patients aged 18-75 who applied to physical medicine and rehabilitation out-patient clinic with chronic shoulder pain between May and July 2024. Patients will be randomly divided into two groups: a mesotherapy group and steroid injection group, using the closed-envelope method. In the first group, a total of 3 sessions of mesotherapy are applied to the shoulder areas of the patients, 7 days apart. A single-session intra-articular 20 mg triamcinolone hexacetonide injection will be administered for patients in group 2. Pain severity, range of motion and functional impairment will evaluated before treatment, 30 minutes and 4 weeks after the injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Mesotherapy | A total of 3 sessions of mesotherapy will be applied to the shoulder area of the patients, 7 days apart in group 1. |
| PROCEDURE | Intra-articular steroid injection | Single session intra-articular 20 mg triamcinolone hexacetonide injection will be applied for patients in group 2. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-10
- First posted
- 2024-09-24
- Last updated
- 2024-12-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06610032. Inclusion in this directory is not an endorsement.